← All comparisons
Head-to-head · FAERS comparison

Alendronate vs Ibandronate: side effects in FDA adverse event reports

How to read this page. FAERS report counts have no denominator; the comparison is of reporting patterns, not of risk. Signals are screened against each FDA label (badges) but not causally assessed. Not medical advice.

At a glance

AlendronateIbandronate
Drug class––
Brand namesAlendronate SodiumIbandronate Sodium
FAERS reports100,3013,077
Serious78%64%
Death outcome11,882295
Boxed warningNoNo

Signals both drugs share

ReactionAlendronateIbandronateLabel screen (A / B)
Femur fracture11,361 · PRR 120.9219 · PRR 48.4Labeled adverse reaction / Labeled adverse reaction

Labeled signals distinctive to Alendronate

Labeled signals distinctive to Ibandronate

Common questions

Which has more reported side effects, Alendronate or Ibandronate?

Alendronate has 100,301 FAERS reports and Ibandronate 3,077. More reports does not mean more dangerous: volume follows how widely and how long a drug has been used, prescription vs over-the-counter status, and publicity. The seriousness share (78% vs 64%) is a better like-for-like signal of the kind of problems reported.

Which side effects do Alendronate and Ibandronate share?

Both drugs carry disproportionality signals for femur fracture. Shared signals often reflect a shared drug class or the condition both are used for.

Is Alendronate or Ibandronate safer?

FAERS cannot answer that: it has no denominator and no comparator. Use this page to see which risks are already on each label and which signals are unlabeled, then check the prescribing information and your clinician for your situation.

Sources: openFDA FAERS pair statistics (OpenPV build 2026-09-14), FDA labels via openFDA, openFDA count queries for seriousness and deaths. Pair chosen because it is a commonly searched comparison. Generated 2026-10-08.